Adelaide, Australia

Stan Gronthos

This inventor holds 20 USPTO granted patents and 16 published patent applications, plus 10 CIPO patents and 12 EPO patents. Top assignees: Angioblast Systems, Inc., Mesoblast, Inc, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stan Gronthos. Retrieved from https://idiyas.com/inventor/stan-gronthos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 165(Granted Patents)


Location History:

  • Rockville, MD (US) (2006)
  • Colonial Light Gardens, AU (2010)
  • Bethesda, MD (US) (2006 - 2012)
  • Colonel Light Gardens, AU (2011 - 2015)
  • South Australia, AU (2015 - 2019)
  • Adelaide, AU (2013 - 2020)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovations of Stan Gronthos: Pioneering Patents and Contributions in Biomedical Research

Introduction

Stan Gronthos is a prominent inventor based in Adelaide, Australia, known for his groundbreaking work in the field of biomedical research. With an impressive portfolio of 21 patents to his name, his innovations focus on enhancing cellular proliferation and developing advanced optical technologies. His contributions have significantly influenced the way we understand and manipulate stem cells and their applications in medicine.

Latest Patents

Among his latest patents, one notable invention is the "Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase," which provides methodologies for obtaining multipotential cells that can be used in various medical treatments. Additionally, his patent on "Method of Increasing Proliferation of Bone Marrow Mononuclear Cells Expressing STRO1" describes techniques to enhance the proliferation and survival of mesenchymal precursor cells using SDF-1, thereby opening new avenues for bone formation therapies.

Career Highlights

Throughout his career, Stan has worked with leading companies in the biomedical field, including Angioblast Systems, Inc. and Mesoblast, Inc. His work has not only led to the development of innovative therapies but has also contributed to advancements in regenerative medicine and cellular biology research.

Collaborations

Stan has collaborated with other notable researchers in his field, including Andrew Zannettino and Paul J Simmons. These partnerships have fostered a dynamic exchange of ideas, further driving the progress of his research initiatives and enhancing the impact of his inventions.

Conclusion

In conclusion, Stan Gronthos has made significant strides in the realm of biomedical innovations with his numerous patents and research contributions. His work exemplifies the intersection of scientific inquiry and practical application, highlighting the vital role inventors play in advancing healthcare solutions. With a continued focus on enhancing cellular therapies and optical technologies, Gronthos remains a key figure in the innovation landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…